Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Icentia is a Canadian medical device and cardiac diagnostics company focused on ambulatory ECG monitoring and related testing services for healthcare institutions. Its flagship commercial product is CardioSTAT, a wire-free, single-use wearable ECG solution for long-term cardiac rhythm monitoring, supported by analysis and reporting services. The company designs and manufactures its products in Canada and has expanded operations beyond Canada into the United Kingdom and the United States. Icentia is positioned at the intersection of medtech, diagnostics, and digital health, with a business model that combines device manufacturing and service delivery for cardiac rhythm detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Icentia.